BPC-157 is a synthetic 15-amino-acid peptide based on a fragment of a gastric protein, studied mostly in rodents for tendon, gut, muscle and bone injury. If you searched for before-and-after results, here is the short version: the photos and week-by-week timelines online are anecdotes, the animal studies are real but are animal studies, and the human data are three small reports without control groups. For the full compound profile, see the BPC-157 compound page. For human trial data, see BPC-157 Human Trials.
Four kinds of claim show up for this search. None of them is evidence of an effect in people.
These come from forum posts and vendor marketing. No controlled study has followed people on BPC-157 week by week. Animal studies measure tissue at fixed points chosen for the model, which say nothing about a human timeline.
Unverifiable: no record of what was in the vial, what else changed, or whether the injury would have healed anyway. Tendon, muscle and gut problems often improve on their own over the same weeks.
Self-reports with no control group. They cannot separate an effect of the compound from rest, physiotherapy, time or expectation.
Usually lifted from a single rodent study and quoted as if it applied to people. Rodent tendon and gut injury models are useful for mechanism, not for predicting a human result.
BPC-157 is not approved for any use and is sold for in-vitro research only. Almost every vendor stocks it, so the ranking below rests on what each one can prove about the vial: a named lab, a batch-matched certificate, and a dated product-page price.
Lowest price at 10/10Premier Bio Labs has the lowest 10mg price of the 6 vendors on the full score, $17.10 with code HEALTH (list $19.00), read 8 Nov. Next is MyPurePeptide at $20.00. Worked out from the dated prices. It does not change the order below.
See it at Premier Bio LabsResearch use only. Prices are list prices read from each vendor's product page on the date shown; code prices are list × (1 − the stated discount), not cart-tested. We earn a commission on partner links; the rubric does not read partner status. How we score.
Animal findings beside the human data. Details and limitations of each human report are on the BPC-157 human trials page.
| Area | Animal studies | Human data |
|---|---|---|
| Tendon & ligament | Rodent injury models: better-organised collagen and faster functional recovery in treated animals versus controls. | None controlled. |
| Gut (GI tract) | Rodent ulcer, fistula and colitis models: the oldest and largest part of the animal literature. | A registered Phase I trial (NCT02637284, 2016) was cancelled without results. |
| Muscle & bone | Rodent muscle and bone injury models: improved healing markers versus controls. | None. |
| Knee pain | — | Lee & Padgett (2021): 16 patients, knee injections, retrospective, no control group. |
| Bladder | — | Lee et al. (2024): 12 patients with interstitial cystitis, no control group. |
| Safety | No toxicity signal reported in the rodent studies. | Lee & Burgess (2025): 2 healthy adults, safety only, no efficacy measured. |
BPC-157 is not FDA-approved for any use, and in 2023 the FDA listed it among substances that raise significant safety concerns for compounding. It is sold for laboratory research only and is not for human or animal consumption.
Not of the kind the search implies. No controlled human trial has reported before-and-after outcomes. The photos and timelines online are anecdotes, and the published human data are three small reports without control groups: 16 knee-pain patients (2021), 12 bladder patients (2024) and a 2-person safety study (2025). The rest of the evidence is in rodents.
Nobody can say for people. Animal studies measured tissue at time points chosen for each injury model, and no human study has tracked a timeline under controlled conditions. Any week-by-week schedule you read was not produced by research.
In rodent tendon and ligament injury models, treated animals showed better-organised collagen and faster functional recovery than untreated controls. These are mechanism studies in animals; they do not establish an effect, a size of effect, or a timeline in humans.
No. BPC-157 is not an approved drug and no human dose has been established; the amounts used in animal studies were chosen for those models and do not translate. Compound Review does not publish dosing or cycling protocols. BPC-157 is sold for laboratory research only and is not for human or animal consumption.
The certificate: a named laboratory you can look up, a lot number that matches the vial, a measured amount in milligrams as well as purity, and an identity test such as mass spectrometry. Our vendor scoreboard scores every vendor on whether its certificates can be checked at the lab.
Purgo Labs, our top-scored vendor, publishes lot-matched certificates you can verify on the laboratory's own site. Code HEALTH takes 20% off. Affiliate link: we earn a commission, and it never changes a score.
Buy BPC-157 at Purgo Labs